Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Infect Dis Now ; 52(1): 1-6, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34896660

ABSTRACT

CONTEXT: In 2007, we performed a nationwide prospective study to assess the epidemiology of encephalitis in France. We aimed to evaluate epidemiological changes 10years later. METHODS: We performed a 4-year prospective cohort study in France (ENCEIF) from 2016 to 2019. Medical history, comorbidities, as well as clinical, biological, imaging, and demographic data were collected. For the comparison analysis, we selected similar data from adult patients enrolled in the 2007 study. We used Stata statistical software, version 15 (Stata Corp). Indicative variable distributions were compared using Pearson's Chi2 test, and means were compared using Student's t-test for continuous variables. RESULTS: We analyzed 494 cases from 62 hospitals. A causative agent was identified in 65.7% of cases. Viruses represented 81.8% of causative agents, Herpesviridae being the most frequent (63.6%). Arboviruses accounted for 10.8%. Bacteria and parasites were responsible for respectively 14.8% and 1.2% of documented cases. Zoonotic infections represented 21% of cases. When comparing ENCEIF with the 2007 cohort (222 adults patients from 59 hospitals), a higher proportion of etiologies were obtained in 2016-2019 (66% vs. 53%). Between 2007 and 2016-2019, the proportions of Herpes simplex virus and Listeria encephalitis cases remained similar, but the proportion of tuberculosis cases decreased (P=0.0001), while tick-borne encephalitis virus (P=0.01) and VZV cases (P=0.03) increased. In the 2016-2019 study, 32 causative agents were identified, whereas only 17 were identified in the 2007 study. CONCLUSION: Our results emphasize the need to regularly perform such studies to monitor the evolution of infectious encephalitis and to adapt guidelines.


Subject(s)
Encephalitis , Adult , Encephalitis/epidemiology , France/epidemiology , Hospitals , Humans , Prospective Studies
2.
Rev Med Interne ; 42(5): 359-362, 2021 May.
Article in French | MEDLINE | ID: mdl-33663872

ABSTRACT

INTRODUCTION: Bing-Neel syndrome is a rare complication of Waldenström macroglobulinemia, defined by monoclonal lymphoplasmocytic cells in the cerebrospinal fluid or in central nervous system biopsy. CASE REPORT: We report a 47-year-old man, with no prior history, who presented a recurrent aseptic lymphocytic meningitis with central nervous manifestations. The presence of a monoclonal lymphoplasmacytic proliferation in cerebrospinal fluid, blood and bone marrow biopsy results was compatible with a diagnosis of Bing-Neel syndrome. Despite the absence of any specific treatment, there was no recurrence of symptoms at 4-month follow-up, and the MRI lesions remained stable. CONCLUSION: We report a case of Bing-Neel syndrome revealed by a recurrent meningitis. Outcome without treatment was favorable at 4-month follow-up.


Subject(s)
Brain Diseases , Meningitis , Waldenstrom Macroglobulinemia , Humans , Magnetic Resonance Imaging , Male , Meningitis/diagnosis , Meningitis/etiology , Middle Aged , Syndrome , Waldenstrom Macroglobulinemia/complications , Waldenstrom Macroglobulinemia/diagnosis
3.
Med Mal Infect ; 44(11-12): 502-8, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25391635

ABSTRACT

OBJECTIVE: We report the features and diagnosis of complicated mumps in previously vaccinated young adults. PATIENTS AND METHODS: We retrospectively studied 7 cases of complicated mumps managed during 1 year at the Bordeaux University Hospital. The diagnosis was suggested by the clinical presentation and confirmed using specific RT-PCR. RESULTS: Five cases of meningitis, 1 of orchitis, and 1 of unilateral hearing impairment were identified. Each of the 7 patients had been previously vaccinated with MMR, 4 had received 2 doses of this vaccine. Blood tests revealed high rates of IgG antibodies, usually considered as sufficient for immunological protection, and every patient had at least 1 positive RT-PCR test for mumps. CONCLUSION: Outbreaks of complicated mumps may still occur despite a broad coverage of MMR vaccination. The clinical presentation suggested mumps but the final diagnosis could only be confirmed by genomic detection of the virus. Unusual viral strains with increased neurovirulence, insufficient population coverage associated with immunity decrease over time may explain outbreaks of complicated mumps. A full vaccine scheme of contact people or a third injection of vaccine for previously vaccinated people who are at risk of developing mumps are required to prevent further spreading of the disease during the outbreak.


Subject(s)
Disease Outbreaks , Measles-Mumps-Rubella Vaccine , Meningitis, Viral/epidemiology , Mumps/epidemiology , Orchitis/epidemiology , Vaccination , Adolescent , Adult , Antibodies, Viral/blood , Female , France/epidemiology , Hearing Loss, Unilateral/epidemiology , Hearing Loss, Unilateral/virology , Humans , Immunization, Secondary , Immunoglobulin G/blood , Immunoglobulin M/blood , Male , Meningitis, Viral/virology , Mumps/cerebrospinal fluid , Mumps/diagnosis , Mumps/virology , Mumps virus/immunology , Mumps virus/isolation & purification , Orchitis/virology , Retrospective Studies , Risk , Vaccine Potency , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL